Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Intercure Ltd. Create: Alert

All | News | Filings
Date FiledTypeDescription
11/17/2021 6-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the Month of November 2021 001-40614 INTERCURE LTD. 85 Medinat ha-Yehudim Street Herzliya, 4676670, Israel Tel: +972 77 460 5012 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Exhibit Index Exhibit No. Description 99.1 Press Release dated November 1...",
"InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month",
"InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth",
"Management’ s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine-month periods ended September 30, 2021 and 2020",
"Interim Condensed Consolidated Financial Statements for the period ended September 30, 2021 (Unaudited)"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy